Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | BBIO | BHC | ||
| Company | Cymabay Therapeutics | Bridgebio Pharma Inc | Bausch Health Companies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 32.49 | 23.04 | 8.16 | ||
| High | 32.50 | 23.63 | 8.22 | ||
| Low | 32.48 | 22.82 | 8.11 | ||
| Last | 32.48 | 23.24 | 8.18 | ||
| Change | +0.01 | +0.20 | -0.01 | ||
| % Change | +0.03% | +0.87% | -0.12% | ||
| Volume | 8,356,200 | 2,067,300 | 579,530 | ||
| 20-Day Average Volume | 3,390,805 | 1,784,715 | 1,959,530 | ||
| Previous Close | 32.47 | 23.04 | 8.19 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 24.46 | 8.81 | ||
| 20-Day Raw Stochastic | 94.12% | 25.98% | 10.46% | ||
| 20-Day Relative Strength | 78.00% | 43.24% | 46.88% | ||
| Weighted Alpha | +247.60 | -27.11 | +8.46 | ||
| Today's Opinion | 100% Buy | 100% Sell | 48% Buy | ||
| Previous Opinion | 100% Buy | 100% Sell | 48% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | -3.61% since 11/14/24 | -6.62% since 11/14/24 | ||
| Low | 32.44 on 03/15/24 | 21.72 on 11/19/24 | 8.11 on 11/21/24 | ||
| High | 32.50 on 03/21/24 | 24.30 on 11/15/24 | 8.73 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | -7.63% since 10/21/24 | +0.12% since 10/21/24 | ||
| Low | 32.15 on 02/22/24 | 21.72 on 11/19/24 | 7.99 on 10/25/24 | ||
| High | 32.50 on 03/21/24 | 27.57 on 11/11/24 | 9.85 on 11/04/24 | ||
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | -9.08% since 08/21/24 | +40.31% since 08/21/24 | ||
| Low | 22.11 on 01/26/24 | 21.72 on 11/19/24 | 5.72 on 08/22/24 | ||
| High | 32.50 on 03/21/24 | 32.06 on 09/05/24 | 9.85 on 11/04/24 | ||
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | -20.63% since 05/21/24 | +24.89% since 05/21/24 | ||
| Low | 12.32 on 10/13/23 | 21.62 on 06/24/24 | 3.96 on 07/24/24 | ||
| High | 32.50 on 03/21/24 | 32.06 on 09/05/24 | 9.85 on 11/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 4,354,330 | 3,012,307 | ||
| Shares Outstanding, K | 114,724 | 188,990 | 367,803 | ||
| Annual Sales | 31,070,000 | 9,300,000 | 8,757,000,000 | ||
| Annual Net Income | -105,370,000 | -643,200,000 | -592,000,000 | ||
| Last Quarter Sales | 60,000 | 2,730,000 | 2,510,000,000 | ||
| Last Quarter Net Income | -41,900,000 | -162,040,000 | -85,000,000 | ||
| 60-Month Beta | 0.32 | 1.09 | 0.74 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | -0.86 on 11/12/24 | 1.12 on 10/30/24 | ||
| Latest Earnings Date | 03/21/24 | 11/14/24 | 10/30/24 | ||
| Most Recent Dividend | N/A | N/A | 1.000 on 11/10/10 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 2.18 | ||